David Westenberg
Stock Analyst at Piper Sandler
(4.84)
# 416
Out of 5,055 analysts
559
Total ratings
57.6%
Success rate
19.6%
Average return
Main Sectors:
Stocks Rated by David Westenberg
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NEOG Neogen | Reiterated: Buy | $14 | $12.13 | +15.42% | 27 | Oct 7, 2026 | |
| NEO NeoGenomics | Reiterated: Buy | $21 | $16.88 | +24.41% | 26 | Oct 6, 2026 | |
| ILMN Illumina | Rated: Buy | $225 → $305 | $271.76 | +12.23% | 54 | Sep 28, 2026 | |
| TXG 10x Genomics | Rated: Hold | $47 → $80 | $73.10 | +9.44% | 10 | Sep 28, 2026 | |
| VCYT Veracyte | Reiterated: Buy | $54 | $43.51 | +24.11% | 5 | Sep 17, 2026 | |
| GH Guardant Health | Reiterated: Buy | $193 | $162.99 | +18.41% | 41 | Sep 15, 2026 | |
| MYGN Myriad Genetics | Downgraded: Sell | $8.5 → $2 | $4.15 | -51.81% | 22 | Sep 1, 2026 | |
| TEM Tempus AI | Upgraded: Buy | $56 → $76 | $68.32 | +11.24% | 17 | Sep 1, 2026 | |
| A Agilent Technologies | Reiterated: Hold | $150 | $174.00 | -13.79% | 2 | Aug 27, 2026 | |
| WAT Waters | Upgraded: Buy | $400 → $480 | $436.61 | +9.94% | 3 | Aug 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $45 → $32 | $26.74 | +19.67% | 10 | Aug 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 | $25.62 | +7.34% | 38 | Aug 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $364 | $394.75 | -7.92% | 53 | Aug 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $22.55 | +33.04% | 26 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $135 → $80 | $75.29 | +6.26% | 27 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $130 → $120 | $97.88 | +22.60% | 5 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $21 | $30.26 | -30.59% | 4 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7.5 | $5.40 | +39.02% | 38 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $56 | $139.70 | -59.91% | 4 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $2 | $1.99 | +0.50% | 30 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $85 → $115 | $148.16 | -22.38% | 2 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $15 → $19 | $21.01 | -9.57% | 21 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $300 → $309 | $317.34 | -2.63% | 8 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $63 | $68.61 | -8.18% | 14 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | €80.00 | €86.60 | -7.62% | 2 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $200 | $224.69 | -10.99% | 2 | Jul 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $510 → $600 | $673.20 | -10.87% | 2 | Jul 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | €75.00 | €78.36 | -4.29% | 1 | Jun 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $65 | $72.50 | -10.34% | 1 | Jun 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $775 → $750 | $529.01 | +41.77% | 27 | Feb 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $190 → $200 | $233.43 | -14.32% | 12 | Oct 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | 150p → 190p | 208p | n/a | 6 | Sep 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $3.5 → $3 | $2.78 | n/a | 10 | Nov 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $28 | $3.50 | n/a | 1 | Oct 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $38.02 | n/a | 1 | May 23, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $65 | $178.20 | n/a | 2 | Dec 17, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $1.20 | n/a | 1 | Jun 15, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $362.43 | n/a | 2 | Feb 16, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $52 | $13.87 | n/a | 1 | Jan 4, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $47 | $41.35 | n/a | 1 | Dec 7, 2017 |
Neogen
Oct 7, 2026
Reiterated: Buy
Price Target: $14
Current: $12.13
Upside: +15.42%
NeoGenomics
Oct 6, 2026
Reiterated: Buy
Price Target: $21
Current: $16.88
Upside: +24.41%
Illumina
Sep 28, 2026
Rated: Buy
Price Target: $225 → $305
Current: $271.76
Upside: +12.23%
10x Genomics
Sep 28, 2026
Rated: Hold
Price Target: $47 → $80
Current: $73.10
Upside: +9.44%
Veracyte
Sep 17, 2026
Reiterated: Buy
Price Target: $54
Current: $43.51
Upside: +24.11%
Guardant Health
Sep 15, 2026
Reiterated: Buy
Price Target: $193
Current: $162.99
Upside: +18.41%
Myriad Genetics
Sep 1, 2026
Downgraded: Sell
Price Target: $8.5 → $2
Current: $4.15
Upside: -51.81%
Tempus AI
Sep 1, 2026
Upgraded: Buy
Price Target: $56 → $76
Current: $68.32
Upside: +11.24%
Agilent Technologies
Aug 27, 2026
Reiterated: Hold
Price Target: $150
Current: $174.00
Upside: -13.79%
Waters
Aug 27, 2026
Upgraded: Buy
Price Target: $400 → $480
Current: $436.61
Upside: +9.94%
Aug 26, 2026
Downgraded: Hold
Price Target: $45 → $32
Current: $26.74
Upside: +19.67%
Aug 24, 2026
Reiterated: Buy
Price Target: $28
Current: $25.62
Upside: +7.34%
Aug 24, 2026
Reiterated: Buy
Price Target: $364
Current: $394.75
Upside: -7.92%
Aug 10, 2026
Reiterated: Buy
Price Target: $30
Current: $22.55
Upside: +33.04%
Aug 10, 2026
Reiterated: Hold
Price Target: $135 → $80
Current: $75.29
Upside: +6.26%
Aug 6, 2026
Reiterated: Buy
Price Target: $130 → $120
Current: $97.88
Upside: +22.60%
Aug 6, 2026
Reiterated: Hold
Price Target: $21
Current: $30.26
Upside: -30.59%
Aug 6, 2026
Reiterated: Buy
Price Target: $7.5
Current: $5.40
Upside: +39.02%
Aug 6, 2026
Reiterated: Hold
Price Target: $56
Current: $139.70
Upside: -59.91%
Aug 6, 2026
Reiterated: Hold
Price Target: $2
Current: $1.99
Upside: +0.50%
Aug 5, 2026
Rated: Buy
Price Target: $85 → $115
Current: $148.16
Upside: -22.38%
Aug 4, 2026
Reiterated: Hold
Price Target: $15 → $19
Current: $21.01
Upside: -9.57%
Aug 4, 2026
Reiterated: Hold
Price Target: $300 → $309
Current: $317.34
Upside: -2.63%
Aug 4, 2026
Reiterated: Buy
Price Target: $63
Current: $68.61
Upside: -8.18%
Jul 29, 2026
Reiterated: Hold
Price Target: €80.00
Current: €86.60
Upside: -7.62%
Jul 27, 2026
Reiterated: Hold
Price Target: $200
Current: $224.69
Upside: -10.99%
Jul 27, 2026
Reiterated: Hold
Price Target: $510 → $600
Current: $673.20
Upside: -10.87%
Jun 11, 2026
Initiated Coverage: Hold
Price Target: €75.00
Current: €78.36
Upside: -4.29%
Jun 11, 2026
Initiated Coverage: Hold
Price Target: $65
Current: $72.50
Upside: -10.34%
Feb 9, 2026
Reiterated: Hold
Price Target: $775 → $750
Current: $529.01
Upside: +41.77%
Oct 27, 2025
Reiterated: Hold
Price Target: $190 → $200
Current: $233.43
Upside: -14.32%
Sep 3, 2025
Reiterated: Buy
Price Target: 150p → 190p
Current: 208p
Upside: n/a
Nov 13, 2023
Rated: Hold
Price Target: $3.5 → $3
Current: $2.78
Upside: n/a
Oct 4, 2021
Initiated Coverage: Buy
Price Target: $28
Current: $3.50
Upside: n/a
May 23, 2019
Initiated Coverage: Hold
Price Target: n/a
Current: $38.02
Upside: n/a
Dec 17, 2018
Upgraded: Buy
Price Target: $65
Current: $178.20
Upside: n/a
Jun 15, 2018
Initiated Coverage: Hold
Price Target: n/a
Current: $1.20
Upside: n/a
Feb 16, 2018
Downgraded: Hold
Price Target: n/a
Current: $362.43
Upside: n/a
Jan 4, 2018
Upgraded: Buy
Price Target: $52
Current: $13.87
Upside: n/a
Dec 7, 2017
Initiated Coverage: Buy
Price Target: $47
Current: $41.35
Upside: n/a